Vascular Endothelial Growth Factor Inhibitor
Where is Ranibizumab made?
6 companies sell it under their own name. Their labels name 1 factory in Singapore.
Singapore 1
Companies and their factories
| Company on the label | Factory | Where | Last FDA inspection |
|---|---|---|---|
| Genentech, Inc. Lucentis, Susvimo6 mg per 1 mL, 10 mg per 1 mL, 100 mg per 1 mL · NDC 50242-080, 50242-078, 50242-082 | Roche Singapore Technical Operations Pte. Ltd.Makes the active ingredient and tests it | Singapore, Singapore | Problems found, fixed voluntarilyNov 2025 |
| Biogen MA Inc. Byooviz10 mg per 1 mL · NDC 64406-019 | The label doesn't name the factory. Plants this company names for other drugs | ||
| Coherus Oncology, Inc. Cimerli0.3 mg per 0.05 mL, 0.5 mg per 0.05 mL · NDC 70114-440, 70114-441 | The label doesn't name the factory. Plants this company names for other drugs | ||
| Harrow Eye, LLC Byooviz10 mg per 1 mL · NDC 82667-018 | The label doesn't name the factory. Plants this company names for other drugs | ||
| Sandoz Inc. Cimerli0.3 mg per 0.05 mL, 0.5 mg per 0.05 mL · NDC 61314-624, 61314-625 | The label doesn't name the factory. Plants this company names for other drugs | ||
| Zydus Pharmaceuticals (USA) Inc. Nufymco0.3 mg per 0.05 mL, 0.5 mg per 0.05 mL · NDC 70710-2172, 70710-2173 | The label doesn't name the factory. Plants this company names for other drugs | ||
Recalls
- Oct 18, 2022 · Class III · Genentech Inc
Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.